372 related articles for article (PubMed ID: 17347152)
41. Heparanase: busy at the cell surface.
Fux L; Ilan N; Sanderson RD; Vlodavsky I
Trends Biochem Sci; 2009 Oct; 34(10):511-9. PubMed ID: 19733083
[TBL] [Abstract][Full Text] [Related]
42. Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis.
Barash U; Cohen-Kaplan V; Dowek I; Sanderson RD; Ilan N; Vlodavsky I
FEBS J; 2010 Oct; 277(19):3890-903. PubMed ID: 20840586
[TBL] [Abstract][Full Text] [Related]
43. Molecular properties and involvement of heparanase in cancer progression and mammary gland morphogenesis.
Zcharia E; Metzger S; Chajek-Shaul T; Friedmann Y; Pappo O; Aviv A; Elkin M; Pecker I; Peretz T; Vlodavsky I
J Mammary Gland Biol Neoplasia; 2001 Jul; 6(3):311-22. PubMed ID: 11547900
[TBL] [Abstract][Full Text] [Related]
44. Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation.
Zetser A; Bashenko Y; Edovitsky E; Levy-Adam F; Vlodavsky I; Ilan N
Cancer Res; 2006 Feb; 66(3):1455-63. PubMed ID: 16452201
[TBL] [Abstract][Full Text] [Related]
45. Heparanase promotes growth, angiogenesis and survival of primary breast tumors.
Cohen I; Pappo O; Elkin M; San T; Bar-Shavit R; Hazan R; Peretz T; Vlodavsky I; Abramovitch R
Int J Cancer; 2006 Apr; 118(7):1609-17. PubMed ID: 16217746
[TBL] [Abstract][Full Text] [Related]
46. Heparanase-2 and syndecan-1 in colon cancer: the ugly ducklings or the beautiful swans?
Giordano RJ
Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):716-8. PubMed ID: 18528290
[TBL] [Abstract][Full Text] [Related]
47. A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer.
Joyce JA; Freeman C; Meyer-Morse N; Parish CR; Hanahan D
Oncogene; 2005 Jun; 24(25):4037-51. PubMed ID: 15806157
[TBL] [Abstract][Full Text] [Related]
48. Heparan sulfate chains of syndecan-1 regulate ectodomain shedding.
Ramani VC; Pruett PS; Thompson CA; DeLucas LD; Sanderson RD
J Biol Chem; 2012 Mar; 287(13):9952-9961. PubMed ID: 22298773
[TBL] [Abstract][Full Text] [Related]
49. Processing of heparanase is mediated by syndecan-1 cytoplasmic domain and involves syntenin and α-actinin.
Shteingauz A; Ilan N; Vlodavsky I
Cell Mol Life Sci; 2014 Nov; 71(22):4457-70. PubMed ID: 24788042
[TBL] [Abstract][Full Text] [Related]
50. Heparanase enhances local and systemic osteolysis in multiple myeloma by upregulating the expression and secretion of RANKL.
Yang Y; Ren Y; Ramani VC; Nan L; Suva LJ; Sanderson RD
Cancer Res; 2010 Nov; 70(21):8329-38. PubMed ID: 20978204
[TBL] [Abstract][Full Text] [Related]
51. Cell surface expression and secretion of heparanase markedly promote tumor angiogenesis and metastasis.
Goldshmidt O; Zcharia E; Abramovitch R; Metzger S; Aingorn H; Friedmann Y; Schirrmacher V; Mitrani E; Vlodavsky I
Proc Natl Acad Sci U S A; 2002 Jul; 99(15):10031-6. PubMed ID: 12097647
[TBL] [Abstract][Full Text] [Related]
52. Heparanase: A Dynamic Promoter of Myeloma Progression.
Purushothaman A; Sanderson RD
Adv Exp Med Biol; 2020; 1221():331-349. PubMed ID: 32274716
[TBL] [Abstract][Full Text] [Related]
53. Crosstalk between tumor cells and lymphocytes modulates heparanase expression.
Theodoro TR; Matos LL; Cavalheiro RP; Justo GZ; Nader HB; Pinhal MAS
J Transl Med; 2019 Mar; 17(1):103. PubMed ID: 30922347
[TBL] [Abstract][Full Text] [Related]
54. COX-2 induction by heparanase in the progression of breast cancer.
Imada T; Matsuoka J; Nobuhisa T; Okawa T; Murata T; Tabuchi Y; Shirakawa Y; Ohara N; Gunduz M; Nagatsuka H; Umeoka T; Yamamoto Y; Nakajima M; Tanaka N; Naomoto Y
Int J Mol Med; 2006 Feb; 17(2):221-8. PubMed ID: 16391819
[TBL] [Abstract][Full Text] [Related]
55. Early growth response gene 1 (EGR1) regulates heparanase gene transcription in tumor cells.
de Mestre AM; Rao S; Hornby JR; Soe-Htwe T; Khachigian LM; Hulett MD
J Biol Chem; 2005 Oct; 280(42):35136-47. PubMed ID: 16093249
[TBL] [Abstract][Full Text] [Related]
56. Genesis of placental sequestration in malaria and possible targets for drugs for placental malaria.
Clark RL
Birth Defects Res; 2019 Jun; 111(10):569-583. PubMed ID: 30919596
[TBL] [Abstract][Full Text] [Related]
57. Targeting heparanase to the mammary epithelium enhances mammary gland development and promotes tumor growth and metastasis.
Boyango I; Barash U; Fux L; Naroditsky I; Ilan N; Vlodavsky I
Matrix Biol; 2018 Jan; 65():91-103. PubMed ID: 28916201
[TBL] [Abstract][Full Text] [Related]
58. Syndecan-1: a dynamic regulator of the myeloma microenvironment.
Sanderson RD; Yang Y
Clin Exp Metastasis; 2008; 25(2):149-59. PubMed ID: 18027090
[TBL] [Abstract][Full Text] [Related]
59. Mammalian heparanase: involvement in cancer metastasis, angiogenesis and normal development.
Vlodavsky I; Goldshmidt O; Zcharia E; Atzmon R; Rangini-Guatta Z; Elkin M; Peretz T; Friedmann Y
Semin Cancer Biol; 2002 Apr; 12(2):121-9. PubMed ID: 12027584
[TBL] [Abstract][Full Text] [Related]
60. [Research advancement on heparanase in tumor metastasis].
Li ZH; Yang SM
Ai Zheng; 2005 Sep; 24(9):1156-60. PubMed ID: 16159446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
